| ACC |
Adrenocortical carcinoma |
79 |
0 |
9 |
ACHN (cell line) |
0 |
2 (GSE143653) |
2 (GSE105556) |
| BLCA |
Bladder Urothelial Carcinoma |
408 |
19 |
10 |
RT112 (cell line) |
2 (GSE193886) |
2 (GSE193886) |
1 (GSE155380) |
| BRCA |
Breast invasivecarcinoma |
1095 |
113 |
74 |
MCF7 (cell line) |
2 (GSE38447,GSE57498) |
2 (GSE38447,GSE57498) |
2 (GSE165570) |
| CESC |
Cervical squamous cell carcinoma and endocervical adenocarcinoma |
304 |
3 |
2 |
HeLa (cell line) |
2 (GSE152020) |
2 (GSE152020) |
2 (GSE176066) |
| CHOL |
Cholangiocarcinoma |
36 |
9 |
5 |
None |
0 |
0 |
0 |
| COAD |
Colon adenocarcinoma |
374 |
51 |
38 |
HCT116 (cell line) |
2 (GSE72622,GSE31755) |
2 (GSE128590,GSE31755) |
1 (GSE200773) |
| DLBC |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
48 |
0 |
0 |
Primary tissue |
0 |
4 (GSE62245) |
2 (GSE168470) |
| ESCA |
Esophageal carcinoma |
183 |
11 |
9 |
TT (cell line) |
1 (GSE131493) |
1 (GSE106563) |
1 (GSE147123) |
| GBM |
Glioblastoma multiforme |
154 |
5 |
9 |
U87 (cell line) |
2 (GSE236253) |
2 (GSE236253) |
1 (GSE147123) |
| HNSC |
Head and Neck squamous cell carcinoma |
520 |
44 |
0 |
SCC25 (cell line) |
2 (GSE149043) |
2 (GSE103554) |
1 (GSE222312) |
| KICH |
Kidney Chromophobe |
66 |
25 |
16 |
None |
0 |
0 |
0 |
| KIRC |
Kidney renal clear cell carcinoma |
448 |
67 |
34 |
G401 (cell line) |
2 (GSE215023) |
2 (GSE120234) |
2 (GSE105235) |
| KIRP |
Kidney renal papillary cell carcinoma |
290 |
32 |
13 |
None |
0 |
0 |
0 |
| LAML |
Acute Myeloid Leukemia |
28 |
0 |
17 |
CUTLL1 (cell line) |
1 (GSE29600) |
1 (GSE115893) |
1 (GSE130140) |
| LGG |
Brain Lower Grade Glioma |
516 |
0 |
22 |
Primary tissue |
0 |
4 (GSE129136) |
0 |
| LIHC |
Liver hepatocellular carcinoma |
371 |
50 |
16 |
HepG2 (cell line) |
4 (GSE26320 GSE26386) |
4 (GSE147042) |
2 (GSE105381) |
| LUAD |
Lung adenocarcinoma |
516 |
59 |
7 |
A549 (cell line) |
6 (GSE91346 GSE91366) |
6 (GSE91248 GSE91214) |
2 (GSE168233) |
| LUSC |
Lung squamous cell carcinoma |
501 |
51 |
0 |
A549 (cell line) |
6 (GSE91346 GSE91366) |
6 (GSE91248 GSE91214) |
2 (GSE168233) |
| MWSO |
Mesothelioma |
87 |
0 |
0 |
None |
0 |
0 |
0 |
| OV |
Ovarian serous cystadenocarcinoma |
293 |
0 |
9 |
SK-OV-3 (cell line) |
2 (GSE118406) |
2 (GSE143653) |
1 (GSE147123) |
| PAAD |
Pancreatic adenocarcinoma |
177 |
4 |
26 |
HPAF-II (cell line) |
0 |
2 (GSE202534) |
0 |
| PCPG |
Pheochromocytoma and Paraganglioma |
178 |
3 |
0 |
None |
0 |
0 |
0 |
| PRAD |
Prostate adenocarcinoma |
492 |
52 |
0 |
PC-3 (cell line) |
2 (GSE96243) |
2 (GSE143653) |
2 (GSE172097) |
| SARC |
Sarcoma |
259 |
2 |
13 |
A673 (cell line) |
2 (GSE144688) |
2 (GSE144688) |
2 (GSE193824) |
| SKCM |
Skin Cutaneous Melanoma |
361 |
1 |
21 |
A375 (cell line) |
2 (GSE75352 GSE75356) |
2 (GSE210423 GSE210424) |
2 (GSE143676) |
| STAD |
Stomach adenocarcinoma |
415 |
34 |
9 |
SNU719 (cell line) |
2 (GSE239987) |
2 (GSE121498) |
1 (GSE135941) |
| TGCT |
Testicular Germ Cell Tumors |
149 |
0 |
14 |
Primary tissue |
1 (GSE31755) |
1 (GSE140806) |
0 |
| THCA |
Thyroid carcinoma |
505 |
59 |
0 |
BCPAP (cell line) |
0 |
1 (GSE120175) |
0 |
| THYM |
Thymoma |
119 |
2 |
13 |
None |
0 |
0 |
0 |
| UCEC |
Uterine Corpus Endometrial Carcinoma |
175 |
24 |
0 |
Primary tissue |
2 (GSE113818) |
2 (GSE94031) |
1 (GSE139397) |
| UCS |
Uterine Carcinosarcoma |
57 |
0 |
0 |
Primary tissue |
4 (GSE142328) |
4 (GSE142328) |
0 |
| UVM |
Uveal Melanoma |
80 |
0 |
9 |
None |
0 |
0 |
0 |